Prakt. Lékáren. 2015; 11(6e): e3-e8

How will diabetes treatment change with new pharmaceuticals?

Milan Kvapil
Interní klinika FN v Motole a 2. LF UK, Praha

Type 2 diabetes mellitus is a heterogeneous disease, with the existing means failing to reach target values of compensation inall patients.Therefore, completely new options for treating hyperglycaemia are beingsought andfound (SGLT2 inhibitors, gliptins, GLP-1receptor agonists). These newpharmaceuticals are at least as effective asolder typesof antidiabetic drugs, but they are certainly safer.Theirkey propertyis minimal riskof hypoglycaemia. They gradually expand the pharmacotherapyoptions for type 2 diabetes andallowfor individual selection and adjustmentof treatment.

Keywords: type 2 diabetes mellitus, gliflozins, SGLT2 inhibitors, gliptins, DPP-4 inhibitors, glycated haemoglobin HbA1c, GLP-1 receptor agonists, liraglutide, exenatide, lixisenatide

Published: September 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kvapil M. How will diabetes treatment change with new pharmaceuticals? Praktické lékárenství. 2015;11(E-verze 6/15):e3-8.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article


    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.